Benefits and adverse effects of ACE inhibitors in patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis.

Sylvaine Bœuf-GibotBruno PereiraJérémy ImbertHanna KerroumThibault MeniniElodie LafargeManuela De CarvalhoPhilippe VorilhonRémy BoussageonHélène Vaillant-Roussel

Published in: European journal of clinical pharmacology (2020)

This review focuses on clinical elements necessary in a shared decision-making process. In practice, general practitioners will be able to use these data to discuss ACE inhibitor treatment with HFrEF patients. This study was registered in the PROSPERO registry under the reference number CRD42018096930.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
healthcare
primary care
angiotensin ii
angiotensin converting enzyme
prognostic factors
electronic health record
big data
quality improvement
machine learning
artificial intelligence
combination therapy
patient reported